Aimei Health Technology Co., Ltd Ordinary Share (NASDAQ:AFJK) — Market Cap & Net Worth
Market Cap & Net Worth: Aimei Health Technology Co., Ltd Ordinary Share (AFJK)
Aimei Health Technology Co., Ltd Ordinary Share (NASDAQ:AFJK) has a market capitalization of $38.12 Million ($38.12 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22845 globally and #4949 in its home market, demonstrating a 1.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aimei Health Technology Co., Ltd Ordinary Share's stock price $12.04 by its total outstanding shares 3166332 (3.17 Million). Review AFJK FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
Aimei Health Technology Co., Ltd Ordinary Share Market Cap History: 2024 to 2026
Aimei Health Technology Co., Ltd Ordinary Share's market capitalization history from 2024 to 2026. Data shows growth from $33.88 Million to $38.12 Million (7.00% CAGR).
Index Memberships
Aimei Health Technology Co., Ltd Ordinary Share is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2163 of 3165 |
Weight: Aimei Health Technology Co., Ltd Ordinary Share's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aimei Health Technology Co., Ltd Ordinary Share Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aimei Health Technology Co., Ltd Ordinary Share's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AFJK by Market Capitalization
Companies near Aimei Health Technology Co., Ltd Ordinary Share in the global market cap rankings as of August 3, 2026.
Key companies related to Aimei Health Technology Co., Ltd Ordinary Share by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #7146 globally with a market cap of $1.48 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10802 globally with a market cap of $643.37 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11242 globally with a market cap of $587.05 Million USD.
- Churchill Capital Corp XI (NASDAQ:CCXI): Ranked #11391 globally with a market cap of $568.14 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7146 | Twenty One Capital, Inc. | NYSE:XXI | $1.48 Billion | $4.27 |
| #10802 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $643.37 Million | $10.11 |
| #11242 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11391 | Churchill Capital Corp XI | NASDAQ:CCXI | $568.14 Million | $13.86 |
Aimei Health Technology Co., Ltd Ordinary Share Historical Marketcap From 2024 to 2026
Between 2024 and today, Aimei Health Technology Co., Ltd Ordinary Share's market cap moved from $33.88 Million to $ 38.12 Million, with a yearly change of 7.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $38.12 Million | -81.19% |
| 2025 | $202.68 Million | +498.22% |
| 2024 | $33.88 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Aimei Health Technology Co., Ltd Ordinary Share was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.12 Million USD |
| MoneyControl | $38.12 Million USD |
| MarketWatch | $38.12 Million USD |
| marketcap.company | $38.12 Million USD |
| Reuters | $38.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aimei Health Technology Co., Ltd Ordinary Share
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors… Read more